OTC · Biotechnology

Awakn Life Sciences Corp. (AWKNF) Stock

$0.07 +0.00% OTC: AWKNF Healthcare

Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.

Valuation

MetricValue
Price$0.07
Market Cap$2.71M
P/E Ratio-0.28
P/B Ratio2.97
P/S Ratio2.58
EPS (TTM)$-0.18
52-Week High$0.13
52-Week Low$0.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-429.34%
ROA-208.09%
ROCE-476.20%
Gross Margin-103.97%
Operating Margin-614.85%
Net Margin-611.40%
Debt/Equity2.71
Current Ratio0.40

Annual Financials (USD)

Metric2020202120222023
Revenue$0$0$1.0M$0
Operating Profit$-1.0M$-10.0M$-9.0M$-4.0M
Net Profit$-1.0M$-16.0M$-9.0M$-5.0M
EPS$-0.10$-0.73$-0.36$-0.18
Op Margin—-4149.3%-614.7%-4493.9%

Balance Sheet (USD)

Metric2020202120222023
Total Assets$1.0M$7.0M$4.0M$1.0M
Total Liabilities$0$4.0M$4.0M$2.0M
Cash$0$2.0M$1.0M$0
Borrowings$0$2.0M$2.0M$0

Latest News

Mastercard completes BVNK acquisition to boost stablecoin infrastructure Electronic Payments · Aug 4, 2026 Aldi, Arla and Polytag test milk bottle recycling traceability pilot Packaging Gateway · Aug 4, 2026 /R E P E A T -- Media advisory - Minister Valdez to announce federal support for crisis hotlines responding to gender-based violence in Newfoundland and Labrador/ CNW Group · Aug 4, 2026 Dr. Reddy's Laboratories Launches Sugammadex Injection Single-Dose Vials in US MT Newswires · Aug 4, 2026 Major Shareholder Announcement GlobeNewswire · Aug 4, 2026

Cash Flow (USD)

Metric2020202120222023
Operating Cash Flow$0$-9.0M$-7.0M$-2.0M
Investing Cash Flow$0$-3.0M$0$0
Financing Cash Flow$1.0M$0$0$0
Net Cash Flow$0$1.0M$-1.0M$0
Free Cash Flow$-1.0M$-10.0M$-7.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.13
FCF Yield-193.28%
Quick Ratio0.40
Interest Coverage-34.50
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATIPATI Physical Therapy, Inc. $0.68 +0.00% -0.03 $2.98M 0.00%
BRRGFBerGenBio ASA $97.09 +0.00% -1.26 $9.49B 0.00%
CIMVFPideka Group Inc. $0.01 +0.00% -1.16 $2.51M 0.00%
DLTNFDelta 9 Cannabis Inc. $0.01 -1.95% -0.05 $3.04M 0.00%
EEVVFEve & Co Incorporated $0.08 +0.00% -0.29 $2.86M 0.00%

About Awakn Life Sciences Corp.

Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.

Awakn Life Sciences Corp. is headquartered in CA.

Awakn Life Sciences Corp. (AWKNF) stock trades at $0.07 with a market capitalization of $2.71M. The stock is valued at a price-to-earnings (P/E) ratio of -0.28, price-to-book of 2.97, price-to-sales of 2.58. Over the past 52 weeks the stock has ranged between $0.05 and $0.13, and currently trades 46.2% below its 52-week high.

On profitability, Awakn Life Sciences Corp. generates a return on equity (ROE) of -429.34%, return on capital employed of -476.20%, an operating margin of -614.85%, a net profit margin of -611.40%.

Official website: solvonis.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides